Yatharth Hospital & Trauma Care ServicesQ3 FY24

Yatharth Hospital & Trauma Care Services Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,109.55P/E: 56.1Market Cap: ₹10.7K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2
  • Revenue grew 21% year-on-year in Q3, reflecting robust growth across specialties.
  • Nine months FY24 revenue increased 31% year-over-year.
  • Revenue growth driven by higher ARPOB and increased complexity of procedures.
  • Bed occupancy improved to 52%-53%, expected to rise further with seasonal trends ending.
  • Oncology revenue surged more than tenfold YoY; gastroenterology, pulmonology, nephrology, urology, and cardiology also posted strong growth.
  • Expansion plans include doubling bed capacity, especially in Noida Extension and Greater Noida hospitals, to optimize occupancy.
  • Addition of new specialties such as radiation and robotic surgeries to attract more patients.
  • Medical tourism focus expected to significantly boost ARPOB and revenues.
  • Anticipate reaching optimized utilization in newer hospitals within 2-3 years, contributing to volume and revenue growth.
  • Continued infrastructure upgrades at hospitals to enhance patient experience and competitiveness.

See what Yatharth Hospital & Trauma Care Services management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes
  • There is no mention of any current or planned new fundraising through debt or equity in the transcript.
  • The company has highlighted a strong balance sheet with a net cash position of approximately INR 284 crores.
  • The acquisition of the Faridabad hospital is being funded through internal resources (corporate reserves and existing cash) without raising new debt.
  • The company reported a significant reduction in finance costs due to prudent financial management and lower borrowing expenses.
  • No statements indicate plans for issuing equity or raising additional debt for ongoing or future expansions.
  • The focus remains on organic and inorganic expansion financed through existing cash reserves and internal accruals.

See what Yatharth Hospital & Trauma Care Services management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Acquisition of Asian Fidelis Hospital (200-bed super specialty hospital in Faridabad) for INR 1,160 million, expected to complete by March 2024; hospital ready to be operationalized immediately.
  • Brownfield expansion plans:
  • - Greater Noida Hospital bed capacity to increase from 400 to 600 beds.
  • - Noida Extension Hospital bed capacity to increase from 450 to 700 beds.
  • Acquired land parcels adjacent to both Greater Noida and Noida Extension hospitals for expansion.
  • Expected capex per bed for expansions around INR 70 lakhs.
  • Construction/ramp-up to commence soon, with weather improvement in Delhi NCR cited as a factor for starting.
  • Strategic focus on doubling bed capacity over the next three years through a combination of greenfield and brownfield expansions.
  • No debt financing planned for the Faridabad acquisition; to be funded from cash reserves and corporate reserves.

Track Yatharth Hospital & Trauma Care Services — get its next earnings analysis in your feed

How does Yatharth Hospital & Trauma Care Services rank vs peers in Healthcare Services?

Pro feature
ThisYatharth Hospital & Trauma Care Services
Rev 2Mar 3

How does Yatharth Hospital & Trauma Care Services rank in Healthcare Services?

Compare Yatharth Hospital & Trauma Care Services against every Healthcare Services company (Q3 FY24) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →